Work

LB 01.2 Emicizumab Prophylaxis Instead of Immunosuppressive Therapy in Patients with Acquired Hemophilia A (AHA)

Year: 2023

Type: article

Source: Research and Practice in Thrombosis and Haemostasis

DOI: 10.1016/j.rpth.2023.100289

Authors: A. Tiede, C. Hart, P. Knoebl, R. Greil, J. Oldenburg, U. Sachs, W. Miesbach, C. Pfrepper, K. Trautmann-Grill, K. Holstein, J. Pilch, P. Möhnle, C. Schindler, C. Weigt, D. Schipp, M. May, C. Dobbelstein, S. Werwitzke, R. Klamroth

Language: English

Topic: Hemophilia Treatment and Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $2,250

OpenAlex ID: W4388601428

FWCI:

Cites:

Cited by:

Related to: 10